4-甲基-N1-(3-苯基丙基)-1,2-苯二胺
4-METHYL-N1-(3-PHENYLPROPYL)BENZENE-1,2-DIAMINE;JSH-23;LogP;4-Methyl-N1-(3-phenylpropyl)-1,2-phenylenediamine;4-methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine;B Activation Inhibitor II, JSH-23;JSH 23;NF-κ4-methyl-N1-(3-phenylpropyl)-1,2-benzenediamine;AK175962;JSH23;4-Methyl-N~1~-(3-phenylpropyl)benzene-1,2-diamine;AOB2674;NF-kappaB activation inhibitor II;HMS3653C16;BCP09944;FD5025;IN1201;s7351;KS-0;AC-33089;HMS3886H13;AKOS005931310;AKOS005931310;CHEBI:94768;CHEBI:94768;4-methyl-N(1)-(3-phenylpropyl)benzene-1,2-diamine;4-methyl-N(1)-(3-phenylpropyl)benzene-1,2-diamine;SW218183-2;SW218183-2;SCHEMBL1424836;SCHEMBL1424836;MFCD09753595;MFCD09753595;4-Methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine;4-Methyl-1-N-(3-phenylpropyl)benzene-1,2-diamine;FT-0672095;FT-0672095;4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine;4-Methyl-N1-(3-phenylpropyl)benzene-1,2-diamine;749886-87-1;749886-87-1;BS-18051;BS-18051;HY-13982;HY-13982;CHEBI:131326;CHEBI:131326;M2734;M2734;DTXSID20587909;DTXSID20587909;NFKB-activation-inhibitor-II;NFKB-activation-inhibitor-II;NF kappa B Activation Inhibitor II, JSH-23;NF kappa B Activation Inhibitor II, JSH-23;EX-A2083;EX-A2083;4-methyl-n1-(3-phenyl-propyl)-benzene-1,2-diamine;4-methyl-n1-(3-phenyl-propyl)-benzene-1,2-diamine;BRD-K83354763-001-02-9;BRD-K83354763-001-02-9;CHEMBL4303329;CHEMBL4303329;CCG-266875;CCG-266875